Sinus Therapeutic Drugs Market will reach US$ 4.29 Bn by 2030

The global sinus therapeutic drugs market will reach US$ 4.29 Bn by 2030, growing at a steady CAGR during 2020-2030, according to a research conducted by ESOMAR-certified firm, Future Market Insights (FMI)

The development of biologics is amongst the most important factors catalysing the sinus therapeutic drugs market. Omalizumab is garnering interest of researchers and drug manufacturers alike. It has obtained the approval all across the Europe and the US to treat severe allergic asthma.

In adults, sinus infections could be attributed to sinus glands having structural deformities, nasal polyps, and history of infection to respiratory tract, weakened immunity.

In children, sinus-related infections could be caused due to a pacifier, getting unduly exposed to second-hand smoke, feeding at the time of laying down, and likewise. Moreover, fungal infections and pollutants drive sinusitis.

Key Takeaways

  • Steroid nasal sprays held the largest market share in 2019 and the scenario is expected to continue in the upcoming period as well.
  • North America accounted for more than 30% of market share in 2019
  • Antibiotics remain a first line of defence, and this category is likely to grow at steady pace through 2030
  • Covid-19 outbreak has diverted the research towards nasal drug delivery, which is likely to benefit even sinus therapeutic drugs market.

Get Report Sample Copy @

Key Participant Insights

The global market is set to witness a staggering growth in the forecast period. The market players are batting for organic as well as inorganic mode of expansion.

For instance –

  • In Jul 2020, Tiziana announced submission of patent application for Foralumab’s nasal administration. Foralumab is a 100% human Anti-CD3 monoclonal antibody to treat Covid-19 patients.
  • In Jun 2019, Sanofi and Regeneron Pharmaceuticals, Inc. announced approval of Dupixent (dupilumab) by the US FDA to be used with the other medicines for treating CRSwNP (chronic rhinosinusitis with nasal polyposis).

The key market players covered by FMI include Bausch Health, Nоvаrtіѕ АG, Ѕun Рhаrmасеutісаl Іnduѕtrіеѕ, Іnс., Rеddу’ѕ Lаbоrаtоrіеѕ, Іnс., Теа Рhаrmасеutісаl Іnduѕtrіеѕ Ltd., Frеѕеnіuѕ Каbі UЅА, Јоhnѕоn & Јоhnѕоn, Рfіzеr Іnс., Јаnѕѕеn Рhаrmасеutісаlѕ, Іnс., and GlaxoSmithKline plc.

“Upsurge in drug delivery systems for ascertaining increased consumption of sinus therapeutic drugs to propel the market” – says the FMI Analyst.

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global sinus therapeutic drugs market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The study provides compelling insights on sinus therapeutic drugs market on the basis of drug class (Аntіhіѕtаmіnеѕ, Аnаlgеѕісѕ, Ѕulрhоnаmіdеѕ, Соrtісоѕtеrоіdѕ, Аntіbіоtісѕ, NSAID’s, and Оthеr Drug Сlаѕѕеѕ), type of disease (Acute Sinusitis, Sub-acute Sinusitis, Chronic Sinusitis), route of administration (Oral, Topical, Injectable), and distribution channel (hospital pharmacies, retail pharmacies, online pharmacies) across seven major regions

Speak To Analyst For Queries about Report @

Table of Content

  1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

  1. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusions and Exclusions

  1. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Drug Development Trends

  1. Key Success Factors

4.1. Adoption Analysis of Sinus Therapeutic Drugs

4.2. Regulatory Scenario

4.3. Reimbursement Scenario

4.4. Pipeline Analysis

4.5. Key Promotional Strategies, By Manufacturers

  1. Sinus Therapeutic Drug Market Demand (Size in US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

5.1. Historical Market Value (US$ Mn) Analysis, 2015-2019

5.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030

5.2.1. Y-o-Y Growth Trend Analysis

5.2.2. Absolute $ Opportunity Analysis

  1. Market Background

6.1. Macro-Economic Factors

6.1.1. Global GDP Growth Outlook

6.1.2. Per Capita Healthcare Expenditure Outlook

6.2. Forecast Factors – Relevance & Impact

6.2.1. Growing Prevalence of Severe Allergic Asthma

6.2.2. Cost of Sinus Therapeutic Drug

6.2.3. Consolidation of Healthcare Industry

6.2.4. Increase in Patient Pool

6.3. Value Chain

6.4. Market Dynamics


Leave a comment

Your email address will not be published. Required fields are marked *